Is there a generic for Desonide?

Yes. The FDA Orange Book lists 20 approved generic (ANDA) applications for Desonide, referencing the brand DESONATE. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Desonide?

DESONATE (NDA 021844, LEO PHARMA AS) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What patents protect Desonide?

The Orange Book lists 1 patent against Desonide products, with the earliest listed expiry in 2027. Listed patents cover the drug substance, drug product, or approved methods of use, and a generic launching before they expire must file a Paragraph IV certification.

What dosage forms of Desonide are approved?

Desonide is approved in the following dosage forms: aerosol, foam, cream, gel, lotion, ointment.

FDA Orange Book · active-ingredient family

Desonide

Desonide is approved as 5 brand and 20 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DESONATE · NDA 021844

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · aerosol, foam, cream, gel, lotion, ointment

Product	Applicant	Application	TE	Approved
DESONATERLD	LEO PHARMA AS	NDA 021844	—	Oct 20, 2006
VERDESORLD	GENUS	NDA 021978	—	Sep 19, 2006
DESONIDERLD	PADAGIS US	NDA 017010	—	Approved Prior to Jan 1, 1982
DESONIDERLD	PADAGIS US	NDA 017426	AB	Approved Prior to Jan 1, 1982
DESOWEN	GALDERMA LABS LP	NDA 019048	AB	Dec 14, 1984

Generic (ANDA) products (20)

Product	Applicant	Application	TE	Approved
DESONIDE	ALEMBIC	ANDA 214396	AB	Dec 08, 2022
DESONIDE	ALEMBIC	ANDA 213632	AB	Aug 24, 2020
DESONIDE	SENORES PHARMS	ANDA 202470	—	May 11, 2020
DESONIDE	CADILA	ANDA 210198	AB	Nov 20, 2019
DESONIDE	ALEMBIC	ANDA 212473	AB	Oct 23, 2019
DESONIDE	PAI HOLDINGS PHARM	ANDA 212002	—	Mar 12, 2019
DESONIDE	ENCUBE ETHICALS	ANDA 210998	AB	Jan 30, 2019
DESONIDE	ENCUBE	ANDA 207855	—	Sep 28, 2017
DESONIDE	GLENMARK SPECLT	ANDA 209494	—	Sep 26, 2017
DESONIDE	GLENMARK PHARMS LTD	ANDA 209996	—	Sep 15, 2017
DESONIDE	GLENMARK SPECLT	ANDA 209729	—	Jul 24, 2017
DESONIDE	HIKMA	ANDA 208836	—	Mar 27, 2017
DESONIDE	TARO	ANDA 202161	AB	Oct 31, 2014
DESONIDE	FOUGERA PHARMS	ANDA 075860	AB	Mar 19, 2002
DESONIDE	FOUGERA PHARMS	ANDA 075751	AB	Mar 12, 2001
DESONIDE	SUN PHARMA CANADA	ANDA 074254	AB	Aug 03, 1994
DESONIDE	COSETTE PHARMS NC	ANDA 074027	AB	Sep 28, 1992
DESONIDE	SUN PHARMA CANADA	ANDA 073548	AB	Jun 30, 1992
DESOWEN	GALDERMA LABS LP	ANDA 072354	—	Jan 24, 1992
DESOWEN	GALDERMA LABS LP	ANDA 071425	—	Jun 15, 1988

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
8460641	Aug 13, 2027	in 1 yr 2 mo	ProductU-1412

Desonide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo